Treatment of epidermolysis bullosa simplex with dupilumab

J Dermatol. 2024 Apr;51(4):e131-e132. doi: 10.1111/1346-8138.17037. Epub 2023 Nov 10.

Authors

Xiaofang Sun¹, Jianping Zhang¹, Qiuyan Yang¹, Jinran Lin²

Affiliations

¹ Department of Dermatology, The Second Affiliated Hospital of Jiaxing University, Zhejiang, China.
² Department of Dermatology, Huashan Hospital, Fudan University, Shanghai, China.

PMID: 37950437
DOI: 10.1111/1346-8138.17037

No abstract available

Publication types

Letter

MeSH terms

Antibodies, Monoclonal, Humanized / therapeutic use
Epidermolysis Bullosa Simplex*
Epidermolysis Bullosa*
Humans
Mutation

Substances

dupilumab
Antibodies, Monoclonal, Humanized

Grants and funding

SHDC22022302/Clinical Research Plan of SHDC